Table 1 Overdiagnosis to mortality reduction ratio (OMRR) for various studies and the corresponding author’s attitudes to mammography screening as assessed by experts in polarised research (1: Very negative to screening, 2: Negative to screening, 3: Neutral to screening, 4: Positive to screening, 5: Very positive to screening)
Institution/corresponding author | Overdiagnosis to mortality reduction ratio (OMRR) | Attitudes to screening | References |
|---|---|---|---|
EUROSCREEN group/Dr. Eugenio Paci | 4:8 = 0.5 | 5 | |
Florentine screening program/Dr. Eugenio Paci | 6:10 = 0.6 | 5 | [27] |
The Norwegian Research Council (NRC)/Professor Roar Johnsen | 5:1 = 5 | 2 | [28] |
The Norwegian Breast Cancer Screening Program (NBCSP)/Professor Solveig Hofvind | 17:10 = 1.7 | 5 | [29] |
Cochrane Collaboration/Director Peter Gøtzsche | 10:1 = 10 | 1 | |
The Swedish Two-County randomized trial of mammographic screening for breast cancer | 4.3: 8.8 = 0.5 | 4 | [17] |
The UK Breast Screening Programme in England/Dr. Prue C Allgood | 2.3: 5.7 = 0.4 | ||
Marmot report (UK)/Professor Sir Michael Marmot | 3:1 = 3 | 4 | [32] |
U.S. Preventive Services Task Force (USPSTF)/Dr. Albert L. Siu | 19:7 = 2.71 | 4 | [33] |